Vertex Pharmaceuticals Aktie
WKN: 882807 / ISIN: US92532F1003
|
12.02.2026 22:09:35
|
Vertex Pharmaceuticals Inc. Reports Rise In Q4 Bottom Line
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) reported earnings for its fourth quarter that Increases, from last year
The company's earnings came in at $1.191 billion, or $4.65 per share. This compares with $913.0 million, or $3.50 per share, last year.
Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $1.287 billion or $5.03 per share for the period.
The company's revenue for the period rose 9.5% to $3.190 billion from $2.912 billion last year.
Vertex Pharmaceuticals Inc. earnings at a glance (GAAP) :
-Earnings: $1.191 Bln. vs. $913.0 Mln. last year. -EPS: $4.65 vs. $3.50 last year. -Revenue: $3.190 Bln vs. $2.912 Bln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vertex Pharmaceuticals Inc.
Analysen zu Vertex Pharmaceuticals Inc.
Aktien in diesem Artikel
| Vertex Pharmaceuticals Inc. | 379,30 | 2,04% |
|